Firas S. Ahmed, MD, MPH
Radiologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Body Imaging, Genitourinary Imaging, Hepatobiliary and Pancreatic Imaging, Virtual CT Colonography.
About Me
- Associate Attending Radiologist
I am a board-certified radiologist with expertise in abdominopelvic imaging. I have experience in a variety of medical imaging methods, including computed tomography (CT) scan, magnetic resonance imaging (MRI), ultrasound, plain radiography, and virtual colonoscopy (also known as CT colonography).
Throughout my residency, fellowship, and post-fellowship practice, I focused on cancer imaging, given its pivotal role in detecting cancer, measuring its extent within the body, assessing response to therapy, and post-remission surveillance.
Read more
In my work at Memorial Sloan Kettering Cancer Center, I collaborate closely with surgeons, oncologists, and other clinicians to evaluate patients with cancer. I have a deep understanding of just how important it is for the radiologist to be vigilant and thorough, especially in cancer imaging, where subtle changes across exams can reflect tumor response or resistance to therapy. The radiologist’s awareness of these small but important details can help treating clinicians make an early, needed decision to change the patient’s treatment protocol.
My cancer imaging research focuses on radiomics (mineable data from medical imaging) and other quantitative imaging techniques. In my studies, I strive to utilize quantitative imaging parameters (already obtained with each scan) that cannot be seen by the human eye but can help provide further information about the nature of a tumor and its aggressiveness. Providing this additional information to clinicians may help them make better therapeutic decisions, ultimately helping patients.
A radiologist is a doctor with special training in using imaging to diagnose and treat disease. Imaging includes X-rays, computed tomography (CT), and magnetic resonance imaging (MRI).
My Specialties
- Body Imaging, Genitourinary Imaging, Hepatobiliary and Pancreatic Imaging, Virtual CT Colonography.
Education
- MD, University of Baghdad-College of Medicine
Residencies
- Diagnostic Radiology, Columbia University/New York-Presbyterian Hospital
Awards and Honors
- Fulbright Scholarship
Fellowships
- Abdominal Imaging and Intervention, Harvard University/Brigham and Women’s Hospital
Board Certifications
- Radiology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, HMO
MSK has a tentative agreement with Cigna to continue coverage in 2024.
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Contact and Location
Dr. Ahmed sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Dercle L, Zhao B, Gönen M, Moskowitz CS, Firas A, Beylergil V, Connors DE, Yang H, Lu L, Fojo T, Carvajal R, Karovic S, Maitland ML, Goldmacher GV, Oxnard GR, Postow MA, Schwartz LH. Early Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis. JAMA Oncol. 2022 Mar 1;8(3):385-392. doi: 10.1001/jamaoncol.2021.6818. PMID: 35050320; PMCID: PMC8778619.
Movassaghi M, Ahmed F, Patel H, Luk L, Hyams E, Wenske S, Shaish H. Association of Patient and Imaging-Related Factors With False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions. Urology. 2022 Sep;167:165-170. doi: 10.1016/j.urology.2022.04.026. Epub 2022 May 6. PMID: 35533767.
Read more
Lu L, Ahmed FS, Akin O, Luk L, Guo X, Yang H, Yoon J, Hakimi AA, Schwartz LH, Zhao B. Uncontrolled Confounders May Lead to False or Overvalued Radiomics Signature: A Proof of Concept Using Survival Analysis in a Multicenter Cohort of Kidney Cancer. Front Oncol. 2021 May 27;11:638185. doi: 10.3389/fonc.2021.638185. PMID: 34123789; PMCID: PMC8191735.
Ahmed FS, Akin O, Shaish H, Luk L, Guo X, Yang H, Zabor E, Ostrovnaya I, Hakimi AA, Zhao B, Schwartz LH. Nonenhancing Component of Clear Cell Renal Cell Carcinoma on Computed Tomography Correlates With Tumor Necrosis and Stage and Serves as a Size-Independent Prognostic Biomarker. J Comput Assist Tomogr. 2019 Jul/Aug;43(4):628-633. doi: 10.1097/RCT.0000000000000877. PMID: 31162237; PMCID: PMC6629492.
Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010 Jan 21;362(3):217-27. doi: 10.1056/NEJMoa0808836. PMID: 20089972; PMCID: PMC2887729.
Visit PubMed for a full listing of Dr. Ahmed’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Firas S. Ahmed discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].